# Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients

> **NCT05311852** · NA · COMPLETED · sponsor: **Department of Neurorehabilitation, Hospital of Vipiteno-Sterzing (BZ) Italy** · enrollment: 34 (actual)

## Conditions studied

- Fatigue
- Cognitive Deficit
- COVID-19
- Neurophysiologic Abnormality

## Interventions

- **DIETARY_SUPPLEMENT:** palmitoylethanolamide co-ultramicronized with antioxidant flavonoid luteolin (PEA-LUT)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05311852
- **Lead sponsor:** Department of Neurorehabilitation, Hospital of Vipiteno-Sterzing (BZ) Italy
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-16
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05311852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05311852, "Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05311852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*